Advanced

Cervixcancer en klinisk utmaning

Bjurberg, Maria LU ; Beskow, Catharina; Kannisto, Päivi LU and Lindahl, Gabriel (2015) In Lakartidningen 112.
Abstract

Cervical cancer is the third most common female cancer world wide. In Sweden, some 450 cases are diagnosed annually. One out of three affected Swedish women is under the age of 40. Survival for all stages is 73 % in Sweden. Human papilloma virus (HPV) can be detected in the majority of all cervical cancers. Treatment consists of surgery for early stages, and a combination of chemoradiation and brachytherapy for locally advanced disease. For metastatic disease, the treatment is palliative. Late side effects after treatment may have serious impact on the quality of life. There is a strong need for more efficient treatment of metastatic disease. Current lines of research include surgical strategies, optimised radiotherapy, neoadjuvant... (More)

Cervical cancer is the third most common female cancer world wide. In Sweden, some 450 cases are diagnosed annually. One out of three affected Swedish women is under the age of 40. Survival for all stages is 73 % in Sweden. Human papilloma virus (HPV) can be detected in the majority of all cervical cancers. Treatment consists of surgery for early stages, and a combination of chemoradiation and brachytherapy for locally advanced disease. For metastatic disease, the treatment is palliative. Late side effects after treatment may have serious impact on the quality of life. There is a strong need for more efficient treatment of metastatic disease. Current lines of research include surgical strategies, optimised radiotherapy, neoadjuvant therapy, targeted therapy, and immunotherapy including therapeutic vaccines.

(Less)
Please use this url to cite or link to this publication:
author
alternative title
Cervical cancer is a clinical challenge
publishing date
type
Contribution to journal
publication status
published
subject
in
Lakartidningen
volume
112
publisher
Sveriges Läkarförbund
external identifiers
  • Scopus:84973409589
ISSN
1652-7518
language
Swedish
LU publication?
no
id
d31adaae-72c8-4629-bdf2-be968e7a07ff
date added to LUP
2016-07-13 12:20:23
date last changed
2016-11-08 15:05:34
@misc{d31adaae-72c8-4629-bdf2-be968e7a07ff,
  abstract     = {<p>Cervical cancer is the third most common female cancer world wide. In Sweden, some 450 cases are diagnosed annually. One out of three affected Swedish women is under the age of 40. Survival for all stages is 73 % in Sweden. Human papilloma virus (HPV) can be detected in the majority of all cervical cancers. Treatment consists of surgery for early stages, and a combination of chemoradiation and brachytherapy for locally advanced disease. For metastatic disease, the treatment is palliative. Late side effects after treatment may have serious impact on the quality of life. There is a strong need for more efficient treatment of metastatic disease. Current lines of research include surgical strategies, optimised radiotherapy, neoadjuvant therapy, targeted therapy, and immunotherapy including therapeutic vaccines. </p>},
  author       = {Bjurberg, Maria and Beskow, Catharina and Kannisto, Päivi and Lindahl, Gabriel},
  issn         = {1652-7518},
  language     = {swe},
  month        = {12},
  publisher    = {ARRAY(0x6649520)},
  series       = {Lakartidningen},
  title        = {Cervixcancer en klinisk utmaning},
  volume       = {112},
  year         = {2015},
}